CMX Research Inc. collaborates with an elite portfolio of clients. They range from domestic and large global Pharmaceutical organizations, emerging Biotech firms and Device companies.
CMX is a niche CRO that started as a Site Management Organization (SMO) in 1992. CMX continues to maintain strong relationships with our sponsors and provide customer satisfaction. CMX has an established relationship with our network of investigators resulting in better than expected recruitment. With an active physician as CEO, CMX understands clinical issues that drive research and can be helpful in designing patient friendly protocols without sacrificing regulatory issues.